GRACE Workshop on Lower Respiratory Tract Infections, Prague 2007
 |
|
Course Overview
The GRACE project is designed around the broad theme of controlling antibiotic resistance in the context of community respiratory infections, since these are the major targets for much antibiotic prescribing. The complex nature of lower respiratory tract infections is reflected in the various diseases, syndromes, microbial pathogens and host responses. As such, these infections are responsible for much morbidity and the use of healthcare resources which in turn have significant economic implications. This workshop provides in a shared session an overview on host-pathogen interactions in the lung and focuses subsequently in two parallel sessions either on the bacteriology of respiratory tract infections or on the epidemiology and the economic impact of common respiratory infections. |
| GRACE Workshop on Lower Respiratory Tract Infections, Prague 2007 |  |
| Introduction to host defences of the lung in health and disease
C. Greene (Dublin, Ireland) | |  | |  | |  |  | | | | | | Introduction to host-bacterial interaction - from colonisation to invasion
P. Hermans (Nijmegen, Netherlands) | |  | |  | |  |  | | | | | | An overview of the cellular, molecular and cytokine response to exogenous agents
R. Schumann (Berlin, Germany) | | | | | | | | | | | | | The immune response to acute lung infection - local and systemic
T. Welte (Hanover, Germany) | | | |  | |  |  | | | | | | Research in progress - Why GRACE? The challenges faced by primary care clinicians in managing LRTI
T. Verheij (Utrecht, Netherlands) | | | |  | |  |  | | | | | | Research in progress - Implementing the largest ever prospective clinical study of LRTI in the community
J. Nuttall (Cardiff, United Kingdom) | | | |  | |  |  | | | | | | Research in progress - First GRACE findings
K. Hood (Cardiff, United Kingdom) | | | |  | |  |  | | | | | | Research in progress - GRACE studies: the next steps
T. Verheij (Utrecht, Netherlands) | | | |  | | | | | | | | | Streptococcus pneumoniae: a model for acute lung infection
T. Van Der Poll (Amsterdam, Netherlands) | |  | |  | |  |  | | | | | | Host response to chronic lung infection
G. Rohde (Bochum, Germany) | |  | |  | |  |  | | | | | | Mycobacterium tuberculosis: a model for chronic lung infection
R. Bals (Marburg, Germany) | | | |  | |  |  | | | | | | Bacterial quorum sensing and lung infection
M. Camara (Nottingham, United Kingdom) | |  | | | | | | | | | | | An introduction to the microbial epidemiology of community-acquired LRTI
M. Woodhead (Manchester, United Kingdom) | |  | |  | | | | | | | | | Current and future microbiological laboratory investigation of LRTI
G. Ieven (Edegem, Belgium) | |  | |  | | | | | | | | | Streptococcus pneumoniae – a biological and genetic profile
B. Henriques-Normark (Stockholm, Sweden) | |  | |  | | | | | | | | | Haemophilus influenzae – a biological and genetic profile
D. Crook (Oxford, United Kingdom) | | | | | | | | | | | | | The application of mathematical modelling in profiling community LRTI
D. Smith (Cambridge, United Kingdom) | |  | |  | | | | | | | | | The impact of environmental pollutants on lung infections
G. Viegi (Pisa, Italy) | |  | |  | |  |  | | | | | | Acute bronchitis: impact on antibiotic use and misuse
T. Verheij (Utrecht, Netherlands) | |  | |  | |  |  | | | | | | Chronic bronchitis from the stable phase to exacerbation: cost of failure and management
M. Miravitlles (Barcelona, Spain) | |  | |  | |  |  | | | | | | Legionella, Mycoplasma and Chlamydia - contrasting features of intracellular pathogens
F. Blasi (Milan, Italy), P. Tarsia (Milan, Italy) | |  | |  | |  |  | | | | | | Mycobacterium tuberculosis - genetic and molecular markers of infection
F. Drobniewski (London, United Kingdom) | |  | | | | | | | | | | | Anaerobic bacteria and the lung
E. Nagy (Szeged, Hungary) | | | |  | |  |  | | | | | | Staphylococcus aureus – a microbiological profile of an emerging respiratory pathogen
M. Bonten (Utrecht, Netherlands) | | | |  | |  |  | | | | | | Asthma and infection: new epidemiology and new aetiologies
A. Papi (Ferrara, Italy) | |  | |  | | | | | | | | | Cystic fibrosis in children and adults: is the social and economic impact changing?
M. Bakker (Rotterdam, Netherlands) | |  | |  | |  |  | | | | | | The epidemiology and impact of Streptococcus pneumoniae in different populations. Is vaccine changing the natural history?
A. Ortqvist (Stockholm, Sweden) | |  | |  | |  |  | | | | | | Community-acquired pneumonia: profiling the healthcare and economic burden
M. Woodhead (Manchester, United Kingdom) | |  | |  | |  |  | | | | |
|
|
WHAT YOU CAN FIND HERE  |
|
|
PDF journal article, handouts & slides |
|
|
Slide presentations |
|
|
Webcasts |
|
|
Multimedia files for portable devices |
FROM PREVIOUS COURSES  |
|
|
|
|
|